drugset / Trial / NCT00240279

The Effect of Rosuvastatin on Aortic Stiffness in Hemodialysis Patients in the AURORA Study

NCT00240279

Phase 3 Completed 10 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the effect of rosuvastatin compared to placebo on the aortic stiffness in hemodialysis patients as measured by pulse wave velocity (at 3, 6 and 12 months)

Timeline

Start
2003-01
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule

Indications